AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteAF-DX 384 is a drug which acts as a selective antagonist of the muscarinic acetylcholine receptors.
More Information Supplier PageAF-DX 384 is a drug which acts as a selective antagonist of the muscarinic acetylcholine receptors.
More Information Supplier PageAfatinib is an irreversible EGFR/HER2 inhibitor with an IC50 of 14 nM for in vitro potency against HER2.
More Information Supplier PageAfatinib is an irreversible EGFR/HER2 inhibitor with an IC50 of 14 nM for in vitro potency against HER2.
More Information Supplier PageAfatinib is an irreversible EGFR/HER2 inhibitor with an IC50 of 14 nM for in vitro potency against HER2.
More Information Supplier PageAfegostat was an experimental drug for the treatment of certain forms of Gaucher’s disease. The substance was used in form of the tartrate. Isofagomine (IFG) is an acid ??-glucosidase (GCase) active site inhibitor that acts as a pharmacological chaperone.
More Information Supplier PageAfegostat was an experimental drug for the treatment of certain forms of Gaucher’s disease. The substance was used in form of the tartrate. Isofagomine (IFG) is an acid ??-glucosidase (GCase) active site inhibitor that acts as a pharmacological chaperone.
More Information Supplier PageAfegostat was an experimental drug for the treatment of certain forms of Gaucher’s disease. The substance was used in form of the tartrate. Isofagomine (IFG) is an acid ??-glucosidase (GCase) active site inhibitor that acts as a pharmacological chaperone.
More Information Supplier PageAfuresertib, also known as GSK2110183, is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. It binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Activation of […]
More Information Supplier PageAfuresertib, also known as GSK2110183, is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. It binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Activation of […]
More Information Supplier PageAfuresertib, also known as GSK2110183, is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. It binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Activation of […]
More Information Supplier PageAfzelin is a flavonol glycoside. It is the rhamnoside of kaempferol. It is found in Nymphaea odorata.
More Information Supplier PageAfzelin is a flavonol glycoside. It is the rhamnoside of kaempferol. It is found in Nymphaea odorata.
More Information Supplier PageAfzelin is a flavonol glycoside. It is the rhamnoside of kaempferol. It is found in Nymphaea odorata.
More Information Supplier PageTyrphostin AG 957 is a potent tyrosine kinase inhibitor. Selectively blocks the tyrosine kinase activity of human p210bcr-abl (Ki = 750 nM) over p140c-abl (Ki = 10 ??M).
More Information Supplier PageTyrphostin AG 957 is a potent tyrosine kinase inhibitor. Selectively blocks the tyrosine kinase activity of human p210bcr-abl (Ki = 750 nM) over p140c-abl (Ki = 10 ??M).
More Information Supplier PageTyrphostin AG 957 is a potent tyrosine kinase inhibitor. Selectively blocks the tyrosine kinase activity of human p210bcr-abl (Ki = 750 nM) over p140c-abl (Ki = 10 ??M).
More Information Supplier PageTyrphostin AG 957 is a potent tyrosine kinase inhibitor. Selectively blocks the tyrosine kinase activity of human p210bcr-abl (Ki = 750 nM) over p140c-abl (Ki = 10 ??M).
More Information Supplier PageAG-014699 (Rucaparib) is a PARP inhibitor that inhibits poly(ADP-ribose) polymerase (PARP) is a key enzyme in DNA repair.
More Information Supplier PageAG-014699 (Rucaparib) is a PARP inhibitor that inhibits poly(ADP-ribose) polymerase (PARP) is a key enzyme in DNA repair.
More Information Supplier PageAG-014699 (Rucaparib) is a PARP inhibitor that inhibits poly(ADP-ribose) polymerase (PARP) is a key enzyme in DNA repair.
More Information Supplier PageAG-014699 (Rucaparib) is a PARP inhibitor that inhibits poly(ADP-ribose) polymerase (PARP) is a key enzyme in DNA repair.
More Information Supplier PageAG-014699 (Rucaparib) is a PARP inhibitor that inhibits poly(ADP-ribose) polymerase (PARP) is a key enzyme in DNA repair.
More Information Supplier PageAG-24322 is a second generation CDK inhibitor. AG-024322 is a potent inhibitor of CDK1, CDK2, and CDK4 that produces cell-cycle arrest and antitumor activity in preclinical models.
More Information Supplier PageAG-24322 is a second generation CDK inhibitor. AG-024322 is a potent inhibitor of CDK1, CDK2, and CDK4 that produces cell-cycle arrest and antitumor activity in preclinical models.
More Information Supplier PageAG-24322 is a second generation CDK inhibitor. AG-024322 is a potent inhibitor of CDK1, CDK2, and CDK4 that produces cell-cycle arrest and antitumor activity in preclinical models.
More Information Supplier PageAG-1024 (Tyrphostin) is a specific inhibitor of insulin-like growth factor-1 (IGF-1) and insulin receptor tyrosine kinase activity. Exhibits lower IC50 values for IGF-1 than for the insulin receptor. Also inhibits insulin-stimulated cellular proliferation.
More Information Supplier PageAG-1024 (Tyrphostin) is a specific inhibitor of insulin-like growth factor-1 (IGF-1) and insulin receptor tyrosine kinase activity. Exhibits lower IC50 values for IGF-1 than for the insulin receptor. Also inhibits insulin-stimulated cellular proliferation.
More Information Supplier PageAG-1024 (Tyrphostin) is a specific inhibitor of insulin-like growth factor-1 (IGF-1) and insulin receptor tyrosine kinase activity. Exhibits lower IC50 values for IGF-1 than for the insulin receptor. Also inhibits insulin-stimulated cellular proliferation.
More Information Supplier PageAG-1024 (Tyrphostin) is a specific inhibitor of insulin-like growth factor-1 (IGF-1) and insulin receptor tyrosine kinase activity. Exhibits lower IC50 values for IGF-1 than for the insulin receptor. Also inhibits insulin-stimulated cellular proliferation.
More Information Supplier PageAG-1024 (Tyrphostin) is a specific inhibitor of insulin-like growth factor-1 (IGF-1) and insulin receptor tyrosine kinase activity. Exhibits lower IC50 values for IGF-1 than for the insulin receptor. Also inhibits insulin-stimulated cellular proliferation.
More Information Supplier PageAG-1288 is a tyrosine kinase inhibitor. Has been shown in human amnion cells (IC50 =21 mM) to block glucocorticoid-induced cytotoxicity, TNF??-induced cytotoxicity, and glucocorticoid-induced COX-2 activity.
More Information Supplier PageAG-1288 is a tyrosine kinase inhibitor. Has been shown in human amnion cells (IC50 =21 mM) to block glucocorticoid-induced cytotoxicity, TNF??-induced cytotoxicity, and glucocorticoid-induced COX-2 activity.
More Information Supplier PageAG-1288 is a tyrosine kinase inhibitor. Has been shown in human amnion cells (IC50 =21 mM) to block glucocorticoid-induced cytotoxicity, TNF??-induced cytotoxicity, and glucocorticoid-induced COX-2 activity.
More Information Supplier PageAG-1288 is a tyrosine kinase inhibitor. Has been shown in human amnion cells (IC50 =21 mM) to block glucocorticoid-induced cytotoxicity, TNF??-induced cytotoxicity, and glucocorticoid-induced COX-2 activity.
More Information Supplier PageAG-1478 (Tyrphostin AG-1478) is an inhibitor of EGFR kinase with an IC50 value of 3 nM.
More Information Supplier PageAG-1478 (Tyrphostin AG-1478) is an inhibitor of EGFR kinase with an IC50 value of 3 nM.
More Information Supplier PageAG-1478 (Tyrphostin AG-1478) is an inhibitor of EGFR kinase with an IC50 value of 3 nM.
More Information Supplier PageAG-1478 (Tyrphostin AG-1478) is an inhibitor of EGFR kinase with an IC50 value of 3 nM.
More Information Supplier PageAG-1478 (Tyrphostin AG-1478) is an inhibitor of EGFR kinase with an IC50 value of 3 nM.
More Information Supplier PageAG-17 is an inhibitor of EGF receptor kinase with an IC50 value of 460 ??M in the human epidermoid carcinoma cell line A431.
More Information Supplier PageAG-17 is an inhibitor of EGF receptor kinase with an IC50 value of 460 ??M in the human epidermoid carcinoma cell line A431.
More Information Supplier PageAG-17 is an inhibitor of EGF receptor kinase with an IC50 value of 460 ??M in the human epidermoid carcinoma cell line A431.
More Information Supplier PageAG-17 is an inhibitor of EGF receptor kinase with an IC50 value of 460 ??M in the human epidermoid carcinoma cell line A431.
More Information Supplier PageAG-17 is an inhibitor of EGF receptor kinase with an IC50 value of 460 ??M in the human epidermoid carcinoma cell line A431.
More Information Supplier PageAG 490 is a selective inhibitor of EGF receptor tyrosine kinase (IC50 values are 2 and 13.5 uM for EGFR and ErbB2 respectively).
More Information Supplier PageAG 490 is a selective inhibitor of EGF receptor tyrosine kinase (IC50 values are 2 and 13.5 uM for EGFR and ErbB2 respectively).
More Information Supplier PageAG 490 is a selective inhibitor of EGF receptor tyrosine kinase (IC50 values are 2 and 13.5 uM for EGFR and ErbB2 respectively).
More Information Supplier PageAG 490 is a selective inhibitor of EGF receptor tyrosine kinase (IC50 values are 2 and 13.5 uM for EGFR and ErbB2 respectively).
More Information Supplier PageAG 490 is a selective inhibitor of EGF receptor tyrosine kinase (IC50 values are 2 and 13.5 uM for EGFR and ErbB2 respectively).
More Information Supplier Page
